[Duodenal ulcers that do not heal for a long time]
Klinicheskaia Meditsina
|February 1, 1992
Summary
Slow healing duodenal ulcers are linked to genetics, smoking, ulcer size, and inflammation. Evening acid production and duodenal reflux were higher in non-healing cases, but sucralfate aided healing when other treatments failed.
Area of Science:
- Gastroenterology
- Internal Medicine
Background:
- Duodenal ulcers that do not heal after standard treatment present a clinical challenge.
- Understanding factors contributing to slow ulcer healing is crucial for effective management.
Purpose of the Study:
- To identify factors associated with slow duodenal ulcer healing.
- To evaluate the efficacy of alternative therapies for refractory duodenal ulcers.
Main Methods:
- Investigated 43 duodenal ulcer patients with non-healing ulcers after 8-week treatment.
- Compared physiological parameters between successfully and unsuccessfully treated groups.
- Assessed outcomes of sequential therapy including gastrocepin and sucralfate.
Main Results:
- Hereditary factors, smoking, ulcer size, antral erosions, and duodenitis correlated with slow healing.
- No significant differences in basal/stimulated acid secretion, gastrin, gastric emptying, or pancreatic bicarbonate output were found between groups.
- Slowly healing ulcers showed higher evening acid production, duodenal reflux, and decreased acid sensitivity, leading to increased secretin.
- Sucralfate provided complete healing for non-complicated ulcers unresponsive to prior cimetidine.
Conclusions:
- Multiple factors beyond acid secretion influence duodenal ulcer healing rates.
- Evening hyperacidity and duodenal reflux are associated with delayed healing.
- Sucralfate is a valuable option for achieving healing in refractory duodenal ulcers.
Related Concept Videos
01:30Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...